PET/X LLC
Seattle, WA · Medtech · Private
PET/X scanner - a quantitative molecular breast imaging system combining PET with mammography for early breast cancer therapy response assessment
petxllc.com →- Grants
- $4.9M
- 7 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2016201720182019202020212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · A Sparse-readout Quantitative PET scanner for breast cancer therapy optimization | $299,970 | |
| Federal grant | Department of Health and Human Services · Phase I · A Sparse-readout Quantitative PET scanner for breast cancer therapy optimization | $299,970 | |
| Federal grant | Department of Health and Human Services · Phase I · NeuroPET HD: A low-cost high performance neuro-PET imaging system | $297,021 | |
| Federal grant | Department of Health and Human Services · Phase I · NeuroPET HD: A low-cost, high performance neuro-PET imaging system | $62,898 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · A Sparse-readout Quantitative PET scanner for breast cancer therapy optimization | $1,231,107 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · A Sparse-readout Quantitative PET scanner for breast cancer therapy optimization | $1,967,422 | |
| Federal grant | Department of Health and Human Services · Phase II · A Sparse-readout Quantitative PET scanner for breast cancer therapy optimization | $736,315 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2011 | AUDIODONTICS, LLC | — | — |
| 2012 | BLUEBIRD PHOTONICS, INC | — | — |
| 2013 | Xonotiv LLC | — | — |
| 2014 | PET/X LLC | — | — |
| 2015 | Cohesys Inc. | — | — |
| 2016 | CellDrop Inc | — | — |
| 2017 | NEUROSESSMENTS LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.